TScan Therapeutics, Inc. (TCRX) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$129.77M | -1.8% |
| 2024 | -$127.50M | -42.9% |
| 2023 | -$89.22M | -34.7% |
| 2022 | -$66.22M | -36.2% |
| 2021 | -$48.62M | -86.1% |
| 2020 | -$26.13M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$129.77M | -1.8% |
| 2024 | -$127.50M | -42.9% |
| 2023 | -$89.22M | -34.7% |
| 2022 | -$66.22M | -36.2% |
| 2021 | -$48.62M | -86.1% |
| 2020 | -$26.13M | — |